AIDP Products Expanded to Australia and New Zealand

AIDP, Inc., the distributors of Magtein magnesium L-threonate, a new discovery in the brain health category; KoACT,a patented chelated compound of calcium and hydrolyzed collagen peptides; and enVantec, a proprietary micro-encapsulation technology; has announced that it has retained Pathway International Pty Ltd. to represent its products in Australia and New Zealand. Pathway International will be the exclusive agent for both territories, initially focusing on Magtein, KoACT and enVantec. Pathway International is seeking to secure TGA approval from the Therapeutic Goods Administration (TGA) in Australia for all three products.